Navigation Links
AVEENO(R) Announces Kick-Off of The Skin Cancer Foundation's 2nd Annual 'Road to Healthy Skin' Tour Presented by AVEENO(R) and Rite Aid
Date:5/4/2009

Nationwide Tour Offers Free Skin Cancer Screenings And Education about Skin Cancer Prevention

SKILLMAN, N.J., May 4 /PRNewswire/ -- AVEENO(R), a brand of Johnson & Johnson Consumer Companies, Inc., announces its second year of sponsorship of The Skin Cancer Foundation's "Road to Healthy Skin" tour. The free skin cancer screening tour kicks off today at Pershing Square, just outside of New York City's Grand Central Terminal, and will visit more than 80 locations across the country through September 2009. The tour will offer free, full body skin cancer screenings in a private room inside a 38-foot customized RV, conducted by local board-certified dermatologists who have volunteered their time and expertise.

(Photo: http://www.newscom.com/cgi-bin/prnh/20090504/NY10128 )

Last year the tour attracted almost 7,000 visitors and screened over 3,000 people. Of those screened, more than 3,200 suspicious markings were detected and 39 suspected cases of melanoma were discovered. "Skin cancer is still the most common form of cancer in the United States, but it is also the most preventable and curable form of cancer if it is detected early," says dermatologist Jeanine Downie, MD. "We are proud of the amount of people we screened last year and that we identified over 900 potential skin cancers with 39 of them potentially being the most deadly form - melanoma. We hope to see an increase in the practice of preventative measures so that we can soon report a decrease in the number of new cases of skin cancer as a result of these tours."

According to The Skin Cancer Foundation, there are more cases of skin cancer than the combined incidence of cancers of the breast, prostate, lung and colon; in fact, one in five Americans will develop skin cancer in the course of a lifetime. Despite these staggering statistics, 40 percent of people admit that they never use sunscreen and only 11 percent use an SPF 15 or higher daily. "AVEENO(R) is committed to educating people nationwide about the importance of early detection, the need for an annual skin exam, and the importance of wearing sunscreen every day, all year long - no matter their skin color," says Mike Marquis, Marketing Director for AVEENO(R). "By sponsoring this tour for a second year, AVEENO(R) is confident that we can continue to help raise awareness of skin cancer prevention and detection so people can safely enjoy a healthy outdoor lifestyle."

At each tour stop, visitors will be invited to visit the RV and receive a quick, easy and potentially life-saving full body skin cancer screening. Educational materials will be provided so that visitors can learn how to perform monthly skin checks at-home and how to properly protect themselves from the sun on a daily basis. Samples of the new AVEENO(R) POSITIVELY AGELESS(TM) Sunblock Lotion SPF 70 for Face will be distributed as well as AVEENO(R) CONTINUOUS PROTECTION(R) suncare products for adult and baby. All AVEENO(R) suncare products feature the patented breakthrough sun protection technology, ACTIVE PHOTOBARRIER COMPLEX(TM) specifically created to deliver optimal, broad and photostable UVA/UVB protection with proper use. Wearing sunscreens with the ACTIVE PHOTOBARRIER COMPLEX(TM) daily is a preventative step everyone can take in protecting skin from the sun's harmful rays.

For the tour schedule or to learn more about skin cancer prevention please visit www.SkinCancer.org or www.Aveeno.com.

About AVEENO:

AVEENO is one of the brands of Johnson & Johnson Consumer Products Company, a division of Johnson & Johnson Consumer Companies, Inc. The AVEENO(R) Brand is the leader in ACTIVE NATURALS technology, including oatmeal and soy. Recommended by dermatologists and pediatricians for over 60 years, the Brand is committed to developing breakthrough product formulations with new and existing natural ingredients to deliver real, clinically proven results.

The AVEENO Line includes beauty care products for face, body, baby, hair and sun protection.

All AVEENO(R) POSITIVELY AGELESS(TM) and CONTINUOUS PROTECTION(R) sunblock lotions and sprays contain the patented Active Photobarrier Complex(TM), specifically engineered to deliver very high, very broad and photostable UVA/UVB protection over time with proper use. In addition to featuring the

breakthrough sun protection technology complex, AVEENO(R) POSITIVELY AGELESS(TM) sunblocks contain Natural Shiitake Complex, which is known to aid in visibly reducing the appearance of lines and wrinkles to reveal healthy, younger looking skin, and natural soy and vitamins A, C and E to help shield skin from environmental damage and even skin tone and texture. AVEENO(R) Baby CONTINUOUS PROTECTION(R) with SPF 55 contains natural, skin soothing colloidal oatmeal to help prevent moisture loss.

For more information about the AVEENO Brand and its product offerings, visit: www.Aveeno.com.

About The Skin Cancer Foundation:

Now celebrating its 30th year, The Skin Cancer Foundation is committed to educating the public and medical professionals about sun safety. As leaders in the fight against skin cancer, the Foundation is the only global organization solely devoted to the prevention, detection and treatment of the world's most common cancer. The mission of the Foundation is to decrease the incidence of skin cancer through public and professional education and research. To learn more about the Foundation and its programs, visit www.skincancer.org.


'/>"/>
SOURCE AVEENO(R)
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. AVEENO(R) Announces Sponsorship and Kick-Off of The Skin Cancer Foundations Road to Healthy Skin Tour Presented by AVEENO(R) and Rite Aid
2. Sarnova Announces Acquisition to Expand Bound Tree Medical Business
3. Inverness Medical Innovations, Inc. Announces Offering of $200 Million of Senior Subordinated Notes
4. Healthy Living Network Announces Launch of New Blood Sugar Web Site
5. Governor Rendell Announces Pennsylvanias First Confirmed Case of 2009 A/H1N1 Flu
6. Triple-S Management Corporation Announces Execution of Definitive Agreement to Acquire Managed Care Portfolio of La Cruz Azul de Puerto Rico, Inc.
7. American Academy of Orthopaedic Surgeons Announces Media Orthopaedic Reporting Excellence (MORE) Award Winners
8. IBM Announces New Healthcare Industry Solutions Lab in China
9. VIA Pharmaceuticals Announces Positive Phase 2 Results of VIA-2291 in Cardiovascular Patients Using Serial MDCT Imaging of Coronary Plaque
10. HMS Holdings Corp. Announces First Quarter 2009 Financial Results
11. Healthy Living Network Announces Launch of New Supplement Information Web Site
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/25/2017)... OK (PRWEB) , ... July 25, 2017 , ... ... proud to announce the launch of their partnership to provide the Pharmacist ... the first pharmacy-focused platform in the country with the ability to develop the ...
(Date:7/25/2017)... ... July 25, 2017 , ... Therachat ... will be exhibiting and providing demos of its smart journaling platform at the ... Center in Washington D.C. from August 3-6, 2017. , The APA Annual Convention ...
(Date:7/25/2017)... , ... July 25, 2017 , ... ... ATM provider in the United States, today announced its partnership with financial technology ... , The foundation of the solution lies within Hyosung’s superior ATMs, assisted ...
(Date:7/25/2017)... Jacksonville, Fla. (PRWEB) , ... July 25, 2017 , ... ... employee and father Ezra Clark is taking advantage of a new benefit for employees ... “It really means a lot that the company supports me and other employees as ...
(Date:7/25/2017)... TX (PRWEB) , ... July 25, 2017 , ... SignatureCare ... emergencies in the Austin, TX area 24 Hours a day. , The ... Austin, TX. , “We’ve been open four months now and things are running ...
Breaking Medicine News(10 mins):
(Date:7/25/2017)... and CAMBRIDGE, Massachusetts , July 25, 2017 ... repurposing drugs to treat rare nervous system diseases, has concluded ... develop and market the drug SOM0226 against transthyretin amyloidosis (ATTR). ... very promising results in a Phase 2 study conducted in ... office in the United States ...
(Date:7/24/2017)... July 24, 2017 IBM (NYSE: IBM ) ... Quadrant for Solid-State Arrays (SSA) for the fourth year in ... According to Gartner, "Vendors in the Leaders quadrant have the ... Vision. A vendor in the Leaders quadrant has the market ... the acceptance of new technologies. These vendors demonstrate a clear ...
(Date:7/21/2017)... EDMONTON, Alberta , July 21, 2017 /PRNewswire/ ... University of Alberta in Edmonton, Canada ... partner journal, Schizophrenia 1 , demonstrating that AI ... schizophrenia with 74% accuracy. This retrospective analysis also ... symptoms in schizophrenia patients with significant correlation, based ...
Breaking Medicine Technology: